COVID-19 Series - Executive Compensation Considerations

Fenwick

Conversations from Our Public Company Virtual Situation Room, Episode 3

In this episode, the Fenwick team addresses complex issues facing public company boards and compensation committees as companies adapt to the economic impact of COVID-19, as well as considerations for executive compensation actions, including timing, adjustments of performance targets, exercise of discretion, usage of equity, repricings, expiring equity awards, salary adjustments and related matters.

Go directly to the topic(s) of most interest to you:

• Big picture – 1:36
• Go forward performance metrics and adjusting existing metrics – 4:45
• Executive salary reductions – 10:01
• Re-pricing – 17:32
• Expiring equity grants – 19:00
• 409A considerations – 20:51

Presenters:

• David A. Bell, Co-Chair, Corporate Governance, Fenwick & West LLP
• Robert A. Freedman, Co-Chair, Capital Markets & Public Companies, Fenwick & West LLP
• Elizabeth A. Gartland, Partner, Executive Compensation & Employee Benefits, Fenwick & West LLP
• Scott P. Spector, Partner, Executive Compensation & Employee Benefits, Fenwick & West LLP

More Information, How to Register